TY - JOUR
T1 - Thyroid stimulating hormone levels rise after assisted reproductive technology
AU - Reinblatt, Shauna
AU - Herrero, Belen
AU - Correa, José A.
AU - Shalom-Paz, Einat
AU - Ata, Baris
AU - Wiser, Amir
AU - Morris, David
AU - Holzer, Hananel
N1 - Funding Information:
Acknowledgments The authors wish to thank Negin Zafar and Dr Fady Shehata for their contribution in data collection and database management. This study was funded in part by a research grant from the “Academic Enrichment Fund” of the Department of Obstetrics and Gynecology, McGill University, Montreal, Canada
PY - 2013/10
Y1 - 2013/10
N2 - Purpose: The goal of this study was to determine whether high E2 levels after controlled ovarian hyperstimulation affect TSH. Methods: Patients completing ART cycles between April-October 2010 were eligible for this cohort study. 180 patients were recruited however those with known thyroid disease were excluded. The final analysis included 154 subjects. Blood was collected at each visit during the ART cycle as well as at the pregnancy test. Samples were frozen at -20 C and analyzed together for E2 and TSH using the same assay kit once all patients had completed their cycles. All participants were treated at the McGill University Health Center. A paired t-test was used to study the difference in TSH levels recorded at maximal and minimal Estradiol levels during ovarian stimulation. Multiple regression analysis was then used to determine if factors such as anti-thyroid antibodies and ovarian reserve measures affect this change in TSH. We used multiple imputation methods to account for missing data. Results: As E2 levels rose from low to supra-physiologic levels during treatment, TSH levels also rose significantly. This increase was clinically significant by the time of pregnancy test. The factors that potentially affected the change in TSH were: male factor/tubal factor infertility, type of protocol used as well as the presence of thyroid antibodies. Conclusions: Although TSH increases during ART, this change only becomes clinically significant on the day of pregnancy test. Future studies should examine TSH changes specifically in certain "at-risk" sub-groups such as those with antibodies and known thyroid disease.
AB - Purpose: The goal of this study was to determine whether high E2 levels after controlled ovarian hyperstimulation affect TSH. Methods: Patients completing ART cycles between April-October 2010 were eligible for this cohort study. 180 patients were recruited however those with known thyroid disease were excluded. The final analysis included 154 subjects. Blood was collected at each visit during the ART cycle as well as at the pregnancy test. Samples were frozen at -20 C and analyzed together for E2 and TSH using the same assay kit once all patients had completed their cycles. All participants were treated at the McGill University Health Center. A paired t-test was used to study the difference in TSH levels recorded at maximal and minimal Estradiol levels during ovarian stimulation. Multiple regression analysis was then used to determine if factors such as anti-thyroid antibodies and ovarian reserve measures affect this change in TSH. We used multiple imputation methods to account for missing data. Results: As E2 levels rose from low to supra-physiologic levels during treatment, TSH levels also rose significantly. This increase was clinically significant by the time of pregnancy test. The factors that potentially affected the change in TSH were: male factor/tubal factor infertility, type of protocol used as well as the presence of thyroid antibodies. Conclusions: Although TSH increases during ART, this change only becomes clinically significant on the day of pregnancy test. Future studies should examine TSH changes specifically in certain "at-risk" sub-groups such as those with antibodies and known thyroid disease.
KW - Assisted reproductive technology
KW - Estradiol
KW - Ovarian hyperstimulation
KW - Thyroid function
KW - Thyroid stimulating hormone
UR - http://www.scopus.com/inward/record.url?scp=84887999940&partnerID=8YFLogxK
U2 - 10.1007/s10815-013-0081-3
DO - 10.1007/s10815-013-0081-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23955685
AN - SCOPUS:84887999940
SN - 1058-0468
VL - 30
SP - 1347
EP - 1352
JO - Journal of Assisted Reproduction and Genetics
JF - Journal of Assisted Reproduction and Genetics
IS - 10
ER -